Skip to main content
K. Victoria Barker on Muck Rack

K. Victoria Barker

As seen in: The National Law Review, Lexology, Mondaq, Finnegan Intellectual Property Law Podcasts
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with K. Victoria

Contact K. Victoria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

|
By Antje Brambrink, K. Victoria Barker, Jamie Barcombe
| Mondaq
The UPC Central Division in Milan has revoked European Patent 3854403, which claimed Remdesivir for use in treating SARS-CoV-2 (Covid-19) infection. The decision (UPC_CFI_552/2025, decision of 4 May 2026 –Gilead v Academy of Military Medical Sciences, see here) provides valuable insights for parties on how the UPC assesses inventive step, particularly in the pharmaceutical sector.
Open in Who Shared View Duplicates (2) Issue with article?

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

|
By K. Victoria Barker
| finnegan.com
The UPC Central Division in Milan has revoked European Patent 3854403, which claimed Remdesivir for use in treating SARS-CoV-2 (Covid-19) infection. The decision (UPC_CFI_552/2025, decision of 4 May 2026 –Gilead v Academy of Military Medical Sciences, see here) provides valuable insights for parties on how the UPC assesses inventive step, particularly in the pharmaceutical sector.
Open in Who Shared Issue with article?

Precision Breeding In England: Navigating The New Regulatory Framework

|
By Hannah Whitmore, K. Victoria Barker, Victoria Randall
| Mondaq
On 13 November 2025, England introduced the Genetic Technology (Precision Breeding) Regulations 2025, creating a new regulatory framework for precision bred plants. This move departs from EU GMO (genetically modified organism) rules and aims to accelerate crop innovation while ensuring food and feed safety. Post-Brexit, this represents a significant departure from EU practice. Selective breeding has been known for millennia.
Open in Who Shared Issue with article?
See all 34 articles